Search
Powered By HealthLine
Special Offers
Health Tools
 Allergy Medicine & Treatment
 Cold Symptoms
 Nasal Congestion Causes
 Coughing Causes
 Cold & Flu Remedies
Featured Conditions
 Allergy
 Asthma
 Cold & Flu
 Acid Reflux
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Melt-Away Stent Works Well in Trial


Related Encyclopedia
 border=
Alzheimer's Disease
Aneurysms
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
The On-X Valve PROACT Trial
The On-X Heart Valve: Longevity With Less Reliance on Coumadin
Tissue Valves vs. Mechanical Valves
What is the difference between heart valve repair and replacement?
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Coronary Bypass Surgery
Erectile Dysfunction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
School Lunches Too Fatty and Sugary, Critics Say
Health Tip: Coping With Juvenile Arthritis
Ethnicity May Drive Response to Obesity, Insulin Resistance
Older Americans May Lack Adequate Nutrition
More...


Page:  << Prev | 1 | 2

The polymer of which the Abbott stent is made breaks down to form carbon dioxide and water, "so you don't have a permanent foreign body in the blood vessel," he said. "That gives you more flexibility in the vessel. And some metallic stents are breaking, and the fracture of the metal creates some unpleasant reactions."

Because the polymer stent disappears, "many years later you are still able to work on the vessel," Serruys added. "You don't have a metallic cage that limits expansion of the vessel."

But there is a need for long-term follow-up of the experimental stent, he said, adding, "probably five or seven years down the road. Whenever you have a long-term follow-up, you can make a second attempt with the design. It will be a long process."

Text Continues Below



Still, Serruys said he was "impressed and amazed by the fact that the first attempt was so successful."

A second trial of a new version of the stent is in the planning stage, said study co-investigator Dr. John A. Ormiston, one of New Zealand's top interventional cardiologists and president of the Asia-Pacific Society of Interventional Cardiology. It will be done at the same sites as the first study, and will also have 30 stent recipients.

"There have been important design modifications," Ormiston said of the stent in the new trial. "The scaffold will be different so that it will be stronger. We think we might get even better results than we've had so far."

The trial could begin later this year. If it succeeds, it would be the prelude to a larger international trial that could lead to approval of the new stent for medical use, Ormiston said.

More information

Learn more about stents from the American Heart Association.

Page:  << Prev | 1 | 2

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/14/2008

Related Links
 border=
From Healthscout's partner site on allergy, MyAllergyNetwork.com
QUIZ: Test your knowledge of allergy causes and treatments
DRUGS: Common drugs used to treat allergies
SYMPTOMS: Images and information on allergy symptoms





SOURCES: Patrick W. Serruys, M.D., professor, medicine and interventional cardiology, Erasmus Medical Center, Rotterdam, the Netherlands; Karin Bauer, spokeswoman, Abbott Laboratories, Abbott Park, Ill.; John Ormiston, MBChB, FRACP, FRACR, president, Asia-Pacific Society of Interventional Cardiology; March 15, 2008, The Lancet


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map